May 9, 2017 / 11:49 AM / in 7 months

BRIEF-Promis Neurosciences reports q1 2017 annual results

May 9 (Reuters) - Promis Neurosciences Inc:

* Promis neurosciences announces q1 2017 annual results

* Says announced mr. Daniel geffken to position of chief financial officer

* Promis will focus on progressing pmn 310, its lead development product, to ind submission anticipated by end of 2018

* Promis Neurosciences Inc - . Priority for 2017 is to actively pursue development of precision medicine therapeutics for ad and als

* Promis Neurosciences - net loss for three months ended march 31, 2017 of $1.4 million versus net loss of $670,150 for three months ended March 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below